drugset
drugset / Trial / NCT04958291

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.

NCT04958291 ↗

Phase 1 Completed 25 enrolled Celgene Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and pharmacogenomics (PG) of multiple doses of CC-99677 in healthy Japanese adult participants. This study will be placebo-controlled to appropriately characterize the safety and tolerability of CC-99677.

Timeline

Start
2021-08-03
Primary completion
2021-12-06
Completion
2021-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject GAMCEMETINIB Small molecule — —

Indications

No indication recorded.